Exelon Slid Near a 52-Week Low as Two Banks Cut Their Targets. Here’s Where the Stock Could Go

Key Stats for Exelon Stock

• Current Price: $43.78
• Target Price (Mid): ~$64
• Street Target: ~$49
• Potential Total Return: ~46%
• Annualized IRR: ~9% / year

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>

What Happened?

Exelon Corporation (EXC) closed at $43.78 on August 21, a step from its 52-week low of $42.58, after two Wall Street banks trimmed their price targets in August. Truist cut to $48 from $50 on August 13, keeping a Hold, and Morgan Stanley moved to $53 from $55 while holding Equal Weight. The nation’s largest regulated utility now trades below where most of the Street thinks it belongs, near the bottom of its 52-week range.

The cuts are modest trims, and the analyst range still brackets the price from about $41 to $58, with 15 of 22 rated analysts on Hold. But they land at an awkward moment: Exelon just beat on revenue, reaffirmed guidance, and told investors its platform is built to absorb exactly the regulatory noise the Street keeps flagging. The question is whether the caution is already more than priced in.

Why Management Thinks the Street Is Too Cautious

The target trims followed a July 30 quarter that was better than the stock reaction suggested. Exelon reported adjusted operating earnings of $0.43 per share, up more than 10% year over year but two cents under the $0.45 consensus. Revenue was the standout: $5.97 billion against a $5.43 billion estimate, a 9.96% beat. Shares actually closed up 0.53% on the print, per TIKR’s earnings-reaction data, so the pressure since has come from the August target cuts, not the quarter itself.

On the call, CFO Jeanne Jones tied the quarter to higher distribution and transmission rates at ComEd and PHI, offset by higher credit loss expense at BGE and higher interest at corporate and PECO. Guidance held at $2.81 to $2.91 per share, midpoint or better, backed by 7.9% annualized rate base growth through 2029.

CEO Calvin Butler’s answer to the regulatory worry was direct. Pressed on whether “paper cuts” across jurisdictions threatened the plan, he said “the strength of Exelon’s model is that we’re not dependent on any single jurisdiction, regulatory outcome or growth opportunity,” pointing to past adverse rulings the company absorbed while still meeting its numbers. That is the crux of the disagreement: the Street prices the regulatory friction in Pennsylvania and Maryland as a drag, while management treats geographic diversification as the thing that neutralizes it. The August storms fit the pattern. ComEd reported roughly 410,000 outages after severe weather on August 11 and 12, one more entry in what Butler called 16 major weather events this year, more than in over two decades, and the operating case for the capital Exelon is spending.

A tight PJM grid, where the last capacity auction cleared at its price cap and still fell 6.8 gigawatts short of the region’s reliability need, makes the wires Exelon owns and the roughly $41 billion it plans to invest through 2029 more valuable, not less.

See historical and forward estimates for Exelon stock (It’s free!) >>>

A Discount That’s Hard to Explain on the Wires Alone

For a pure regulated transmission-and-distribution utility, Exelon looks inexpensive against its own peers. Shares trade at a next-twelve-months EV/EBITDA of 9.64x, below the electric-utility peer mean near 11.6x. Constellation Energy, the generation business Exelon spun off, trades at 14.12x and IDACORP at 13.92x, while only cheaper wires names like Portland General at 8.49x undercut it. With the rate base growing 7.9% a year, that gap is hard to justify on fundamentals alone.

Exelon has not produced positive free cash flow in years, its LTM net debt sits near 6x EBITDA, and it funds a heavy capital program partly through equity issuance that dilutes holders. Layer on the open rate cases in Pennsylvania and Maryland, and the market’s hesitation makes sense. The debate is whether a stock near its 52-week low already reflects all of that.

See how Exelon performs against its peers in TIKR (It’s free!) >>>

TIKR Advanced Model Analysis

• Current Price: $43.78
• Target Price (Mid): ~$64
• Potential Total Return: ~46%
• Annualized IRR: ~9% / year

See analysts’ growth forecasts and price targets for Exelon stock (It’s free!) >>>

Two revenue drivers carry the number. The first is rate base growth near 7.9% annually, as approved distribution and transmission rates earn into the base across ComEd, BGE, and PHI. The second is the transmission and storage pipeline, from competitive MISO and PJM awards to the Pittsgrove battery, which adds regulated assets outside the traditional distribution track. On margins, the model assumes the net income margin holds around 14%, helped by the mix shift toward transmission. The primary risk is the funding picture already described: negative free cash flow and roughly 6x leverage leave Exelon dependent on capital markets, and rising rates or equity dilution could erode per-share returns.

The upside case is a regulated utility whose grid grows structurally more valuable as PJM supply stays tight. The downside is a capital-hungry business whose share count and interest burden outrun its rate base growth, leaving the stock to tread water near current levels.

Conclusion

The next real test is ComEd’s grid plan order, expected by December 15, covering roughly $15.3 billion of proposed investment from 2028 through 2031. A constructive order confirms the rate base growth the thesis leans on; a disappointing one, or a fresh rate-case setback in Pennsylvania or Maryland, would validate the trims. Before then, third-quarter earnings show whether August storm costs stayed inside the reaffirmed range, with management guiding Q3 to about 27% of full-year earnings. Come in below that, and the Hold camp looks right. Hold the line, and a stock near its 52-week low with a Street target about 12% higher starts to look like the market pricing caution it has already banked.

See what stocks billionaire investors are buying so you can follow the smart money with TIKR.

Should You Invest in Exelon?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up Exelon, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track Exelon alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Analyze Exelon on TIKR Free →

Looking for New Opportunities?

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!